Related Experiment Video
Updated: Mar 28, 2026

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
[Researches on the change of intestinal barrier function in patients with ulcerative colitis]
Tao Shi1, Jiangpeng Wei, Gang Liu2
1Department of Pathology, General Hospital, Tianjin Medical University, Tianjin 300052, China.
Objective:
To discuss the variation of intestinal barrier and its clinical significance in patients with ulcerative colitis (UC).
Methods:
Specimens were obtained from 200 patients of UC and 40 controls respectively from March 2010 to June 2013. UC samples were classified into three groups as mild (n = 68), moderate (n = 70) and severe (n = 62) according to Mayo classification. Immunohistochemistry was performed to examine the expression of occludin, β-defensin and sIgA, which respectively reflect the changes of mechanical barrier, chemical barrier and immune barrier in intestinal tissue. The result and the clinical data were analyzed.
Results:
Compared with controls, the expression of occludin and sIgA significantly decreased (28.53% ± 2.21% vs 44.28% ± 1.94%, 19.26% ± 1.09% vs 28.36% ± 2.36%, both P < 0.05), β-defensin significantly increased (29.13% ± 1.75% vs 19.71% ± 1.83%, P < 0.05) in UC group. There was a significant difference of occludin levels among different active subgroups (P < 0.05), and the levels decreased significantly with the increase of UC classification (r = -0.753, P < 0.05). β-defensin levels were significant differently among different active subgroups (P < 0.05), and the levels increased significantly with the increase of UC classification (r = 0.698, P < 0.05). There was no significant difference in the sIgA levels among the three stages (P > 0.05). In different gender, age and lesion site, there was no statistically significant difference in expression of three kinds of protein (all P > 0.05).
Conclusion:
UC patients exist intestinal barrier function injury, with the increase of UC classification, the damages of intestinal mechanical barrier and chemical barrier were more obvious.
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs for Treatment of Ulcerative Colitis in IBD
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

